SEOM clinical guidelines in early-stage breast cancer 2015

被引：15

作者：

Garcia-Saenz, J. A. ^{[1
]}

Bermejo, B. ^{[2
]}

Estevez, L. G. ^{[3
]}

Palomo, A. G. ^{[4
]}

Gonzalez-Farre, X. ^{[5
]}

Margeli, M. ^{[6
]}

Pernas, S. ^{[7
]}

Servitja, S. ^{[8
]}

Rodriguez, C. A. ^{[9
]}

Ciruelos, E. ^{[10
]}

机构：

[1] Hosp Clin San Carlos, Madrid, Spain

[2] Hosp Clin Univ, Valencia, Spain

[3] CIOCC Hosp Univ Madrid Sanchinarro, Madrid, Spain

[4] Complejo Asistencial Univ Leon, Leon, Spain

[5] Hosp Univ Quiron Dexeus, Barcelona, Spain

[6] Hosp Univ Germans Trias I Pujol Badalona ICO Bada, Barcelona, Spain

[7] Hosp Duran I Reynals ICO, Barcelona, Spain

[8] Hosp del Mar, Barcelona, Spain

[9] Hosp Univ Salamanca IBSAL, Salamanca, Spain

[10] Hosp Univ 12 Octubre, Madrid, Spain

来源：

CLINICAL & TRANSLATIONAL ONCOLOGY | 2015年 / 17卷 / 12期

关键词：

Early-stage breast cancer; Clinical guidelines; Adjuvant; Neoadjuvant; Genomic platforms; 20-YEAR FOLLOW-UP; NEOADJUVANT CHEMOTHERAPY; ADJUVANT TRASTUZUMAB; DISTANT RECURRENCE; OPEN-LABEL; POSTMENOPAUSAL PATIENTS; GENE-EXPRESSION; PAM50; RISK; TAMOXIFEN; WOMEN;

D O I：

10.1007/s12094-015-1427-3

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Breast cancer is a major public health problem. Despite remarkable advances in early diagnosis and treatment, one in three women may have metastases since diagnosis. Better understanding of prognostic and predictive factors allows us to select the most appropriate adjuvant therapy in each patient. In these guidelines, we summarize current evidence for the medical management of early-stage breast cancer.

引用

页码：939 / 945

页数：7

共 55 条

[1] Chemotherapy (CT) and hormonotherapy (HT) as neoadjuvant treatment in luminal breast cancer patients: results from the GEICAM/2006-03, a multicenter, randomized, phase-II study [J].

Alba, E. ;

Calvo, L. ;

Albanell, J. ;

De la Haba, J. R. ;

Arcusa Lanza, A. ;

Chacon, J. I. ;

Sanchez-Rovira, P. ;

Plazaola, A. ;

Lopez Garcia-Asenjo, J. A. ;

Bermejo, B. ;

Carrasco, E. ;

Lluch, A. .

ANNALS OF ONCOLOGY, 2012, 23 (12) :3069-3074

[2] Comparisons between different polychemotherapy regimens for early breast cancer: meta-analyses of long-term outcome among 100 000 women in 123 randomised trials [J].

Albain, K. ;

Anderson, S. ;

Arriagada, R. ;

Barlow, W. ;

Bergh, J. ;

Bliss, J. ;

Buyse, M. ;

Cameron, D. ;

Carrasco, E. ;

Clarke, M. ;

Correa, C. ;

Coates, A. ;

Collins, R. ;

Costantino, J. ;

Cutter, D. ;

Cuzick, J. ;

Darby, S. ;

Davidson, N. ;

Davies, C. ;

Davies, K. ;

Delmestri, A. ;

Di Leo, A. ;

Dowsett, M. ;

Elphinstone, P. ;

Evans, V. ;

Ewertz, M. ;

Gelber, R. ;

Gettins, L. ;

Geyer, C. ;

Goldhirsch, A. ;

Godwin, J. ;

Gray, R. ;

Gregory, C. ;

Hayes, D. ;

Hill, C. ;

Ingle, J. ;

Jakesz, R. ;

James, S. ;

Kaufmann, M. ;

Kerr, A. ;

MacKinnon, E. ;

McGale, P. ;

McHugh, T. ;

Norton, L. ;

Ohashi, Y. ;

Paik, S. ;

Pan, H. C. ;

Perez, E. ;

Peto, R. ;

Piccart, M. .

LANCET, 2012, 379 (9814) :432-444

[3] Prognostic and predictive value of the 21-gene recurrence score assay in postmenopausal women with node-positive, oestrogen-receptor-positive breast cancer on chemotherapy: a retrospective analysis of a randomised trial [J].

Albain, Kathy S. ;

Barlow, William E. ;

Shak, Steven ;

Hortobagyi, Gabriel N. ;

Livingston, Robert B. ;

Yeh, I-Tien ;

Ravdin, Peter ;

Bugarini, Roberto ;

Boehner, Frederick L. ;

Davidson, Nancy E. ;

Sledge, George W. ;

Winer, Eric P. ;

Hudis, Clifford ;

Ingle, James N. ;

Perez, Edith A. ;

Pritchard, Kathleen I. ;

Shepherd, Lois ;

Gralow, Julie R. ;

Yoshizawa, Carl ;

Allred, D. Craig ;

Osborne, C. Kent ;

Hayes, Daniel F. .

LANCET ONCOLOGY, 2010, 11 (01) :55-65

[4]

[Anonymous], SAN ANT BREAST CANC

[5]

[Anonymous], SAN ANT BREAST CANC

[6]

[Anonymous], CLIN CANC RES

[7]

[Anonymous], J CLIN ONCOL

[8]

[Anonymous], N ENGLAND J MED

[9]

[Anonymous], 2013, J CLIN ONCOL, V31, P5, DOI 10.1200/jco.2013.31.18_suppl.5

[10] Lapatinib with trastuzumab for HER2-positive early breast cancer (NeoALTTO): a randomised, open-label, multicentre, phase 3 trial [J].

Baselga, Jose ;

Bradbury, Ian ;

Eidtmann, Holger ;

Di Cosimo, Serena ;

de Azambuja, Evandro ;

Aura, Claudia ;

Gomez, Henry ;

Dinh, Phuong ;

Fauria, Karine ;

Van Dooren, Veerle ;

Aktan, Gursel ;

Goldhirsch, Aron ;

Chang, Tsai-Wang ;

Horvath, Zsolt ;

Coccia-Portugal, Maria ;

Domont, Julien ;

Tseng, Ling-Min ;

Kunz, Georg ;

Sohn, Joo Hyuk ;

Semiglazov, Vladimir ;

Lerzo, Guillermo ;

Palacova, Marketa ;

Probachai, Volodymyr ;

Pusztai, Lajos ;

Untch, Michael ;

Gelber, Richard D. ;

Piccart-Gebhart, Martine .

LANCET, 2012, 379 (9816) :633-640

← 1 2 3 4 5 6 →